Exelon (NASDAQ:EXC) Given New $51.00 Price Target at Evercore ISI

Exelon (NASDAQ:EXC) had its target price increased by Evercore ISI from $48.00 to $51.00 in a report published on Friday morning,Benzinga reports. They currently have an in-line rating on the stock.

Several other equities research analysts also recently issued reports on the stock. Guggenheim set a $47.00 target price on shares of Exelon and gave the company a “buy” rating in a research note on Tuesday, April 22nd. Morgan Stanley lifted their target price on Exelon from $46.00 to $48.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 20th. Scotiabank increased their price target on Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. BMO Capital Markets lifted their price objective on shares of Exelon from $46.00 to $50.00 and gave the stock an “outperform” rating in a research report on Monday, April 28th. Finally, Barclays increased their price objective on shares of Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a research report on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $48.22.

Exelon Price Performance

NASDAQ:EXC opened at $46.48 on Friday. Exelon has a 52-week low of $34.01 and a 52-week high of $48.11. The company has a market cap of $46.92 billion, a P/E ratio of 18.97, a P/E/G ratio of 2.86 and a beta of 0.39. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.78 and a current ratio of 0.87. The stock’s 50-day simple moving average is $45.06 and its 200 day simple moving average is $41.27.

Exelon (NASDAQ:EXC) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.06. The company had revenue of $6.71 billion for the quarter, compared to analysts’ expectations of $6.30 billion. Exelon had a return on equity of 9.52% and a net margin of 10.68%. The business’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.68 EPS. As a group, sell-side analysts forecast that Exelon will post 2.64 EPS for the current fiscal year.

Exelon Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Monday, May 12th will be given a dividend of $0.40 per share. The ex-dividend date is Monday, May 12th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.44%. Exelon’s payout ratio is presently 65.31%.

Insider Activity

In related news, EVP Colette D. Honorable sold 1,463 shares of the firm’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the transaction, the executive vice president now owns 2,271 shares in the company, valued at approximately $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On Exelon

Several hedge funds have recently bought and sold shares of the company. Norges Bank bought a new position in Exelon in the fourth quarter valued at approximately $479,597,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Exelon by 37.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company’s stock worth $1,039,545,000 after buying an additional 7,483,873 shares in the last quarter. FMR LLC lifted its position in shares of Exelon by 46.9% during the 4th quarter. FMR LLC now owns 17,306,652 shares of the company’s stock worth $651,422,000 after buying an additional 5,524,103 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Exelon by 43.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company’s stock valued at $483,525,000 after acquiring an additional 3,878,687 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Exelon by 109.0% in the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after acquiring an additional 3,068,309 shares during the last quarter. 80.92% of the stock is owned by institutional investors.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.